The current stock price of TRHC is 10.5 USD. In the past month the price increased by 1.16%. In the past year, price increased by 203.47%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| VEEV | VEEVA SYSTEMS INC-CLASS A | 31.02 | 39.47B | ||
| DOCS | DOXIMITY INC-CLASS A | 26.7 | 8.24B | ||
| WAY | WAYSTAR HOLDING CORP | 25.75 | 6.60B | ||
| HTFL | HEARTFLOW INC | N/A | 2.82B | ||
| CERT | CERTARA INC | 18.66 | 1.49B | ||
| SDGR | SCHRODINGER INC | N/A | 1.35B | ||
| TDOC | TELADOC HEALTH INC | N/A | 1.32B | ||
| CCLDO | CARECLOUD INC - CCLD 8 3/4 PERP | 646.5 | 1.10B | ||
| LFMDP | LIFEMD INC - LFMD 8 7/8 PERP | N/A | 1.07B | ||
| PHR | PHREESIA INC | N/A | 1.03B | ||
| GDRX | GOODRX HOLDINGS INC-CLASS A | 8 | 950.40M | ||
| HSTM | HEALTHSTREAM INC | 32.5 | 655.71M |
Tabula Rasa Healthcare, Inc. is a healthcare technology company, which engages in the development of solutions designed for pharmacists, providers, and patients to optimize medication regimens. The company is headquartered in Moorestown, New Jersey and currently employs 1,027 full-time employees. The company went IPO on 2016-09-29. The firm operates through two segments: CareVention HealthCare and MedWise HealthCare. The CareVention HealthCare segment provides its clients, primarily organizations with programs of All-Inclusive Care for the Elderly (PACE), with medication fulfillment services, cloud-based software, pharmacy benefit management (PBM) solutions, and clinical pharmacist services at the point-of-care. PACE is a Centers for Medicare & Medicaid Services (CMS) sponsored program. The MedWise HealthCare segment provides technology-enabled solutions to promote medication safety and adherence to improve patient outcomes and reduce healthcare costs. The technology-enabled solutions revenue model is primarily based on payments on a PMPM basis, payments on a subscription basis, and payments on a fee-for-service basis for each medication safety review and clinical assessment completed.
TABULA RASA HEALTHCARE INC
228 Strawbridge Drive
Moorestown NEW JERSEY 08057 US
CEO: Calvin H. Knowlton
Employees: 1027
Phone: 18666482767.0
Tabula Rasa Healthcare, Inc. is a healthcare technology company, which engages in the development of solutions designed for pharmacists, providers, and patients to optimize medication regimens. The company is headquartered in Moorestown, New Jersey and currently employs 1,027 full-time employees. The company went IPO on 2016-09-29. The firm operates through two segments: CareVention HealthCare and MedWise HealthCare. The CareVention HealthCare segment provides its clients, primarily organizations with programs of All-Inclusive Care for the Elderly (PACE), with medication fulfillment services, cloud-based software, pharmacy benefit management (PBM) solutions, and clinical pharmacist services at the point-of-care. PACE is a Centers for Medicare & Medicaid Services (CMS) sponsored program. The MedWise HealthCare segment provides technology-enabled solutions to promote medication safety and adherence to improve patient outcomes and reduce healthcare costs. The technology-enabled solutions revenue model is primarily based on payments on a PMPM basis, payments on a subscription basis, and payments on a fee-for-service basis for each medication safety review and clinical assessment completed.
The current stock price of TRHC is 10.5 USD. The price increased by 0.86% in the last trading session.
TRHC does not pay a dividend.
TRHC has a ChartMill Technical rating of 9 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
TABULA RASA HEALTHCARE INC (TRHC) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.3).
TABULA RASA HEALTHCARE INC (TRHC) has a market capitalization of 284.02M USD. This makes TRHC a Micro Cap stock.
You can find the ownership structure of TABULA RASA HEALTHCARE INC (TRHC) on the Ownership tab.
ChartMill assigns a technical rating of 9 / 10 to TRHC. When comparing the yearly performance of all stocks, TRHC is one of the better performing stocks in the market, outperforming 99.44% of all stocks.
ChartMill assigns a fundamental rating of 2 / 10 to TRHC. TRHC has a bad profitability rating. Also its financial health evaluation is rather negative.
Over the last trailing twelve months TRHC reported a non-GAAP Earnings per Share(EPS) of -0.3. The EPS increased by 50% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -26.82% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
9 analysts have analysed TRHC and the average price target is 10.71 USD. This implies a price increase of 2% is expected in the next year compared to the current price of 10.5.
For the next year, analysts expect an EPS growth of 94.12% and a revenue growth 21.88% for TRHC